Engineering Neural Stem Cells with Micropatches for Improved Therapy of Traumatic Brain Injury.

IF 16.9
He Xia, Wenjuan Zhou, Dezheng Li, Fan Peng, Chao Wang, Liyang Yu, Jingyi Du, Yang Zheng, Yuanhua Sang, Yu Zhang, Lin Han, Hong Liu, Aijun Hao, Jichuan Qiu
{"title":"Engineering Neural Stem Cells with Micropatches for Improved Therapy of Traumatic Brain Injury.","authors":"He Xia, Wenjuan Zhou, Dezheng Li, Fan Peng, Chao Wang, Liyang Yu, Jingyi Du, Yang Zheng, Yuanhua Sang, Yu Zhang, Lin Han, Hong Liu, Aijun Hao, Jichuan Qiu","doi":"10.1002/anie.202512804","DOIUrl":null,"url":null,"abstract":"<p><p>Transplantation of neural stem cells (NSCs) holds promise for repairing traumatic brain injury (TBI) but their therapeutic performance is hindered due to the low efficient differentiation into neurons. Direct injection of differentiation modulators to the lesion site has limited improvement to neuronal differentiation as they tend to diffuse or be degraded. In the present study, we report a simple and versatile strategy to engineer the NSCs with a micropatch to improve their therapeutic performance in TBI treatment. The micropatches are fabricated through microcontact printing technique and can adhere to the membrane with negligible detachment or internalization within 14 days after surface modification. The micropatches on the cell membrane can move together with stem cells and sustainedly release retinoic acid, a neuronal differentiation modulator, to regulate the surrounding microenvironment of NSCs, improving their neuronal differentiation rate from 28.0% to 54.2%. The micropatch-engineered NSCs can be implanted into the injured brain tissue through a minimally invasive microinjection approach and show outperformance in repairing damaged neural tissue of TBI mice compared to normal stem cells. Overall, this work highlights a new pathway to engineer stem cells and holds great potential in nerve regeneration and neurodegenerative disease treatment.</p>","PeriodicalId":520556,"journal":{"name":"Angewandte Chemie (International ed. in English)","volume":" ","pages":"e202512804"},"PeriodicalIF":16.9000,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Angewandte Chemie (International ed. in English)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/anie.202512804","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Transplantation of neural stem cells (NSCs) holds promise for repairing traumatic brain injury (TBI) but their therapeutic performance is hindered due to the low efficient differentiation into neurons. Direct injection of differentiation modulators to the lesion site has limited improvement to neuronal differentiation as they tend to diffuse or be degraded. In the present study, we report a simple and versatile strategy to engineer the NSCs with a micropatch to improve their therapeutic performance in TBI treatment. The micropatches are fabricated through microcontact printing technique and can adhere to the membrane with negligible detachment or internalization within 14 days after surface modification. The micropatches on the cell membrane can move together with stem cells and sustainedly release retinoic acid, a neuronal differentiation modulator, to regulate the surrounding microenvironment of NSCs, improving their neuronal differentiation rate from 28.0% to 54.2%. The micropatch-engineered NSCs can be implanted into the injured brain tissue through a minimally invasive microinjection approach and show outperformance in repairing damaged neural tissue of TBI mice compared to normal stem cells. Overall, this work highlights a new pathway to engineer stem cells and holds great potential in nerve regeneration and neurodegenerative disease treatment.

工程神经干细胞微贴片改善创伤性脑损伤的治疗。
神经干细胞(NSCs)移植治疗创伤性脑损伤(TBI)有希望,但由于其向神经元的分化效率较低,阻碍了其治疗效果。直接向病变部位注射分化调节剂对神经元分化的改善有限,因为它们容易扩散或降解。在本研究中,我们报告了一种简单而通用的策略,用微贴片来设计NSCs,以提高其在TBI治疗中的治疗性能。微贴片是通过微接触印刷技术制造的,在表面修饰后的14天内可以粘附在膜上,几乎没有脱落或内化。细胞膜上的微贴片可以随干细胞一起移动,并持续释放神经元分化调节剂维甲酸,调节NSCs周围微环境,使其神经元分化率从28.0%提高到54.2%。微补丁工程的NSCs可以通过微创显微注射方法植入损伤的脑组织,并且与正常干细胞相比,在修复创伤性脑损伤小鼠受损的神经组织方面表现出更好的性能。总的来说,这项工作突出了干细胞工程的新途径,在神经再生和神经退行性疾病治疗方面具有很大的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信